The 2021 Medtech Contract Manufacturing Report

innovation hub

Esperance Pharmaceuticals is Profiled in this Database

Updated At 31 May, 2012

Start Free 7 Day Trial Now
Partial description of this company
First-in-class oncology therapeutics to treat female and male cancers utilizing membrane-disrupting peptides to target cancer cells without harming healthy tissue

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Esperance Pharmaceuticals plus 4860 other startups.

Start Free 7 Day Trial Now

Learn More About Esperance Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients